8-K: Ingersoll Rand Achieves Record First Quarter Revenue and Raises Full-Year Guidance

Ingersoll Rand reported record first-quarter revenue, adjusted EBITDA, and adjusted EPS, leading to an increase in full-year guidance.

Summary

• Ingersoll Rand announced record first-quarter results for 2024, with revenues reaching $1,670 million, a 3% increase year-over-year, although organic revenue declined by 1%.
• Adjusted EBITDA for the quarter was $459 million, a 15% increase, with a margin of 27.5%, up 290 basis points from the previous year.
• Adjusted net income was $320 million, or $0.78 per share.
• The company's liquidity stands at $3.5 billion, including $1.5 billion in cash.
• Ingersoll Rand is raising its full-year 2024 Adjusted EBITDA guidance to a range of $1,940 to $2,000 million, up 9% to 12% year-over-year.
• Full-year 2024 Adjusted EPS guidance is also raised to a range of $3.20 to $3.30, up 8% to 11% year-over-year.
• The company's backlog remains strong, up 2% with a book-to-bill ratio of 1.02x.
• Free cash flow was $99 million, down 33% year-over-year, primarily due to the timing of capital expenditures and interest payments.
• The board authorized a $1 billion increase to the company's share repurchase program.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to record results, increased guidance, and a strong liquidity position. However, there are some concerns about the decline in organic revenue and free cash flow, which temper the overall optimism.

Positives

• Ingersoll Rand achieved record first-quarter revenue, adjusted EBITDA, and adjusted EPS.
• The company is raising its full-year guidance for both adjusted EBITDA and adjusted EPS.
• The company maintains a strong liquidity position of $3.5 billion.
• The share repurchase program has been increased by $1 billion.
• The Industrial Technologies and Services segment showed strong growth in adjusted EBITDA.
• The Precision and Science Technologies segment saw a 15% sequential improvement in orders in the Life Sciences end markets.
• The company deployed $143 million to M&A, closing on the acquisitions of Controlled Fluidics and Ethafilter s.r.l.

Negatives

• First quarter orders were down 4%, or 7% organically.
• Organic revenue declined by 1% in the first quarter.
• Free cash flow decreased by 33% year-over-year, primarily due to the timing of capital expenditures and interest payments.
• The Precision and Science Technologies segment saw a 3% decrease in adjusted EBITDA.

Risks

• The company faces risks related to natural disasters, global pandemics, geopolitical tensions, and cyber events.
• There are risks associated with business combinations, including unexpected costs and failure to realize anticipated benefits.
• The company's performance is subject to changes in general economic and industry-specific conditions.
• The company's performance is subject to actions by third parties, including government agencies.
• The company's performance is subject to evolving legal, regulatory and tax regimes.

Future Outlook

Ingersoll Rand is raising its full-year 2024 Adjusted EBITDA guidance to a range of $1,940 to $2,000 million and Adjusted EPS guidance to a range of $3.20 to $3.30, based on strong first-quarter performance and expectations of continued strong commercial and operational performance.

Management Comments

• Our team delivered another strong start to the year with record first quarter revenue, Adjusted EBITDA, and Adjusted EPS, said Vicente Reynal, chairman and chief executive officer of Ingersoll Rand.
• We believe the power of IRX combined with our ownership mindset and leading portfolios strengthens the durability of our company while driving long-term value to shareholders.

Industry Context

The results reflect a strong start to the year for Ingersoll Rand, demonstrating the effectiveness of their IRX program and strategic acquisitions. The company's performance is being driven by strong operational execution and pricing strength, despite some headwinds in specific end markets.

Comparison to Industry Standards

• Ingersoll Rand's adjusted EBITDA margin of 27.5% is strong compared to industrial peers such as Atlas Copco (typically in the 20-25% range) and Parker Hannifin (around 20-22%).
• The company's organic revenue growth of -1% is below some peers who have seen positive growth, but the two-year stack of 20% organic growth shows strong underlying performance.
• The book-to-bill ratio of 1.02x indicates healthy demand, which is in line with industry expectations for companies with strong backlogs.
• The free cash flow decline is a concern, but the company has attributed it to timing issues, which is not uncommon in the industrial sector.

Stakeholder Impact

• Shareholders will benefit from the increased share repurchase program and raised guidance.
• Employees will be impacted by the company's continued focus on operational excellence.
• Customers will benefit from the company's strong product portfolio and service capabilities.
• Suppliers will be impacted by the company's continued growth and M&A activity.

Next Steps

• Ingersoll Rand will host a live earnings conference call on May 3, 2024, to discuss the first quarter results.
• The company will continue to execute its capital allocation strategy, including M&A and share repurchases.

Key Dates

Keywords

Ingersoll Rand, Adjusted EBITDA, Adjusted EPS, Revenue, Orders, Free Cash Flow, Share Repurchase, M&A, Industrial Technologies, Precision Technologies